SK Bioscience to develop COVID-19 Omicron-specific vaccine
As the Omicron COVID-19 variant, which is now the most dominant strain in the world, rapidly spread in Korea, SK Bioscience also started developing Omicron-spec
South Africa Soult Ukpyolsi South Korea United Kingdom Health Security Agency Global Economic Michigan News
Source: northkoreatimes.com